← Leaderboards
Arno W Tilles
Massachusetts General Hospital
$4,868,169
Attributed
$7,890,889
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2005–17$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$7,890,889 · 6
By mechanism
R44$5,571,820 · 2
R43$1,753,352 · 3
K08$565,717 · 1
Top collaborators
- Martin L Yarmush4 shared
- David M Charytan3 shared
- Biju Parekkadan3 shared
- Benjamin M Buehrer2 shared
- Brian Miller2 shared
- Muralikrishna Vemula2 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Elizabeth M. C. Hillman$26,584,494
- Martin L Yarmush$31,545,312
- Noah C Choi$1,358,216
- Biju Parekkadan$9,663,657
- Junfeng Wang$753,630
Others in their field
Top investigators on “Technology”
- David Heimbrook · Leidos Biomedical Research, Inc.$995,338,451
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Eric S Lander · Whitehead Institute For Biomedical Res$606,570,095
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Richard K. Wilson · Washington University$441,856,657
Research focus
TechnologyDevicesCellsBioreactorsDesignBaseDoseSafetyBiotechnologyIn VivoTranslatingPrototypeStem CellsOperationMesenchymal Stem CellsCanis FamiliarisAcuteClinical ResearchInflammationCell SecretionOrganSentinelMarketingScale Up
Grant awards (18)
Stem Cell Bioreactor for Cardiac Care$800,030
R44 · FY2017 · HL · contact PI
Transforming Dialysis into a Controlled Drug Delivery System for Stem Cell Derive$962,626
R44 · FY2016 · DK · contact PI
Stem Cell Bioreactor for Cardiac Care$771,827
R44 · FY2016 · HL · contact PI
Transforming Dialysis into a Controlled Drug Delivery System for Stem Cell Derive$1,006,437
R44 · FY2015 · DK · contact PI
Stem Cell Bioreactor for Cardiac Care$240,729
R44 · FY2015 · HL · contact PI
Transforming Dialysis into a Controlled Drug Delivery System for Stem Cell Derive$1,016,886
R44 · FY2014 · DK · contact PI
Cellular Device for the Treatment of Acute Liver Failure$191,418
R43 · FY2013 · DK · contact PI
Mesenchymal Stem Cell Bioreactor for the Active Treatment of Acute Renal Failure$773,285
R44 · FY2012 · DK · contact PI
Development of a discovery platform based on microfluidics and fluorescent cell f$339,072
R43 · FY2012 · DK
Cellular Device for the Treatment of Acute Liver Failure$307,888
R43 · FY2012 · DK · contact PI
Development of a discovery platform based on microfluidics and fluorescent cell f$349,963
R43 · FY2011 · DK
A Mesenchymal Stem Cell Bioreactor for the Active Treatment of Acute Renal Failur$286,679
R43 · FY2011 · DK · contact PI
A Mesenchymal Stem Cell Bioreactor for the Active Treatment of Acute Renal Failur$278,332
R43 · FY2010 · DK · contact PI
Engineering Embryonic Stem Cell Differentiation into Hepatocytes$118,081
K08 · FY2008 · DK · contact PI
Engineering Embryonic Stem Cell Differentiation into Hepatocytes$115,428
K08 · FY2007 · DK · contact PI
Engineer/Embryonic Stem Cell Differentiation/Hepatocytes$112,852
K08 · FY2006 · DK · contact PI
Engineer/Embryonic Stem Cell Differentiation/Hepatocytes$111,432
K08 · FY2005 · DK
Engineer/Embryonic Stem Cell Differentiation/Hepatocytes$107,924
K08 · FY2004 · DK